Boehringer Ingelheim Pharmaceuticals, Inc. Statement Regarding FDA Approval Of Viramune XR Extended-Release Tablets

Links shared publicly online about this topic.

  • 397
    total visits

Boehringer Ingelheim Pharmaceuticals, Inc. Statement Regarding FDA Approval Of Viramune XR Extended-Release Tablets

medicalnewstoday.com —

The U.S. Food and Drug Administration (FDA) has approved Viramune® XR™ (nevirapine) extended-release tablets, to be used in combination with other antiretroviral agents for the treatment

View full resource at medicalnewstoday.com

Tags: HIV Medication, Diet and Nutrition, Drug, Pharma, FDA, Viramune, Boehringer Ingelheim

  • Share

Most Recently Shared on April 1, 2011 at 8:07 pm By:

HIV_Wisdom OrganizedWisdom HIV

Boehringer Ingelheim Pharmaceuticals, Inc. Statement Regarding FDA Approval Of Viramune XR Extended-Release Tabl... http://bit.ly/giexS5

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

MNT HIV/Aids MNT HIV/Aids

MNT Drug Approvals MNT Drug Approvals

Advertisement